$86.94
-0.370 (-0.424%)
At Close: Aug 04, 2026
Here's Why You Should Add DexCom Stock to Your Portfolio Now
09:01am, Friday, 16'th May 2025
DXCM continues to raise investor optimism due to its strong product portfolio.
5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil
09:11am, Thursday, 15'th May 2025
Five high-flying medical instrument stocks are: DXCM, IDXX, NPCE, CLPT, FMS.
Top Health & Fitness Stocks to Buy for the Wellness Boom
10:01am, Wednesday, 14'th May 2025
The health and fitness boom is fueling demand for gyms, nutrition, and wellness services. Stocks like SFM, HIMS and DXCM are well-positioned to benefit.
Dexcom Announces Promotion of Jake Leach to the Expanded Role of President and COO
08:30am, Tuesday, 13'th May 2025
SAN DIEGO--(BUSINESS WIRE)--Dexcom Announces Promotion of Jake Leach to the Expanded Role of President and COO.
All You Need to Know About DexCom (DXCM) Rating Upgrade to Buy
01:05pm, Monday, 12'th May 2025
DexCom (DXCM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Buy 5 Health and Fitness Stocks to Enhance Your Portfolio Returns
10:10am, Monday, 12'th May 2025
Five Health and Fitness stocks to buy now are: SFM, DXCM, HIMS, UNFI, GDRX.
DexCom Q1 Earnings: Organic Revenue Growth Versus Cost Pressure
11:00am, Friday, 09'th May 2025
DexCom's Q1 2025 earnings show strong growth potential, but cost pressures are impacting margins, leading me to lower my rating from buy to hold. Despite demographic tailwinds and a growing market, gr
DexCom Stock: Earnings Beat and New Market Access Drive Bull Case
07:31am, Thursday, 08'th May 2025
DexCom, Inc. NASDAQ: DXCM has once again demonstrated its formidable position in the continuous glucose monitoring (CGM) market, delivering outstanding first-quarter 2025 financial results that unders
5 Best Stocks of the S&P 500 ETF in the Past Month
11:50am, Monday, 05'th May 2025
The S&P 500 is enjoying its longest winning streak since 2004. We have highlighted the five best stocks in the S&P 500 over the past month.
DexCom: Growth Is Reaccelerating But Don't Ignore The Risks
04:34am, Monday, 05'th May 2025
I initially rated DexCom's stock as sell due to competition and GLP-1 threats, but surprising 1Q25 growth prompts an upgrade to hold. DXCM posted better than expected growth figures in 1Q25, establish
DexCom Stock Rises Despite Q1 Earnings Miss & Lower Margins
02:25pm, Friday, 02'nd May 2025
DXCM's first-quarter 2025 earnings decline despite increasing sales. Its performance in 2025 is expected to be fueled by global growth in CGM adoption, strong Sensor sales and expansion into new marke
Nasdaq Index: Dexcom, Meta, ON Semi Lead US Stocks Rebound on Trade Optimism
01:43pm, Friday, 02'nd May 2025
Nasdaq jumps as Dexcom, Palantir, and ON Semi soar. Jobs report beats forecasts, easing inflation fears and driving US stock market optimism.
Dexcom Stock Is Today's Big Winner After Earnings. Why the Medtech Is Soaring.
11:53am, Friday, 02'nd May 2025
Dexcom, the maker of glucose monitors for patients with diabetes, reports a strong first quarter.
2 Growth Stocks to Buy and Hold for a Decade
04:16am, Friday, 02'nd May 2025
Marketwide challenges, like those created by President Donald Trump's tariff policies, cause many investors to shift their focus to the short term -- leading to panic-selling and a spiraling stock mar
DexCom, Inc. (DXCM) Q1 2025 Earnings Call Transcript
09:04pm, Thursday, 01'st May 2025
DexCom, Inc. (NASDAQ:DXCM ) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ET Company Participants Sean Christensen - VP, Finance & IR Kevin Sayer - Executive Chairman, CEO & President Jereme Sy
Sign In
Buy DXCM